methoxamine has been researched along with Bowel Incontinence in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bush, D; Gruss, HJ; Jacobs, A; Pediconi, C; Scholefield, JH; Simpson, JA | 1 |
Bell, D; Jacobs, A; Pediconi, C | 1 |
Bell, D; Duffin, A; Gruss, HJ; Jacobs, A; Pediconi, C | 1 |
Jones, D; Scholefield, JH; Shing, RN; Siproudhis, L; Walker, D | 1 |
Emmanuel, A; Graf, W; Pediconi, C; Pilot, J; Scholefield, J; Shing, RN; Siproudhis, L; Walker, D; Wexner, S | 1 |
Acheson, AG; Bush, D; Gruss, HJ; Nisar, PJ; Scholefield, JH | 1 |
5 trial(s) available for methoxamine and Bowel Incontinence
Article | Year |
---|---|
A randomised, controlled, crossover study to investigate the safety and response of 1R,2S-methoxamine hydrochloride (NRL001) on anal function in healthy volunteers.
Topics: Adolescent; Adrenergic alpha-1 Receptor Agonists; Adult; Anal Canal; Cross-Over Studies; Double-Blind Method; Fecal Incontinence; Female; Healthy Volunteers; Heart Rate; Humans; Male; Methoxamine; Middle Aged; Stereoisomerism; Suppositories | 2014 |
Randomised clinical trial: study of escalating doses of NRL001 given in rectal suppositories of different weights.
Topics: Adolescent; Adrenergic alpha-1 Receptor Agonists; Adult; Double-Blind Method; Fecal Incontinence; Female; Humans; Male; Methoxamine; Middle Aged; Suppositories | 2014 |
A double-blind, placebo-controlled, randomised, parallel-group, dose-escalating, repeat dose study in healthy volunteers to evaluate the safety, tolerability, pharmacodynamic effects and pharmacokinetics of the once daily rectal application of NRL001 supp
Topics: Administration, Rectal; Adolescent; Adrenergic alpha-1 Receptor Agonists; Adult; Double-Blind Method; Drug Tolerance; Electrocardiography; Electrocardiography, Ambulatory; Fecal Incontinence; Female; Heart Rate; Humans; Male; Methoxamine; Middle Aged; Stereoisomerism; Suppositories; Vital Signs | 2014 |
Libertas: rationale and study design of a multicentre, Phase II, double-blind, randomised, placebo-controlled investigation to evaluate the efficacy, safety and tolerability of locally applied NRL001 in patients with faecal incontinence.
Topics: Adrenergic alpha-1 Receptor Agonists; Double-Blind Method; Drug Tolerance; Fecal Incontinence; Methoxamine; Patient Satisfaction; Stereoisomerism; Suppositories; Treatment Outcome | 2014 |
Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response.
Topics: Demography; Fecal Incontinence; Female; Humans; Male; Methoxamine; Middle Aged; Patient Satisfaction; Placebos; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2016 |
1 other study(ies) available for methoxamine and Bowel Incontinence
Article | Year |
---|---|
Intra-anal application of L-erythro methoxamine gel increases anal resting pressure in patients with incontinence.
Topics: Administration, Rectal; Adrenergic alpha-Agonists; Adult; Aged; Anal Canal; Blood Pressure; Fecal Incontinence; Female; Gels; Humans; Male; Methoxamine; Middle Aged; Pressure; Pulse; Treatment Outcome | 2007 |